Palliative Care COPY Flashcards
Principles of pain management
- Understand cause to optimize treatment
- Appropriate level of WHO ladder
- Use adjuvants where necessary
- Use oral where possible
- Assess regularly
- Encourage patients to take an active role in the management of their pain
Causes of pain
- Nociceptive
- Somatic
- Visceral
- Neuropathic
Opioids for pain management
- 1st line = morphine
- Background and breakthrough
Breakthrough pain management
- Regular opioid + Breakthrough opioid
- Regular opioid = typically long acting 12 or 24 hour preparations.
- Breakthrough = immediate release preparations, given PRN when pain worsens.
Monitoring
- Pain charts
- Individual dose titration
Syringe drivers
- SC
- Steady plasma conc. of drug
- Dose reviewed every 24 hours, titrated up/down as needed - dependent on symptoms/side effects.
- May still require breakthrough doses
When are syringe drivers useful?
- Intractable pain
- Vomiting
- Severe dysphagia (patient too weak to swallow or unconscious)
- Several drugs can be combined into one syringe - management of multiple symptoms.
Compatibility charts
- For syringe drivers
- Summarises compatibility information available for drug combinations
- Determines if drugs can be mixed or if they will precipitate
- Maximum concentrations
3 examples of palliative care emergencies
- Malignant hypercalcaemia
- Neutropenic sepsis
- Malignant spinal cord compression (MSCC)
Malignant hypercalcaemia
- Palliative care emergency
- Sign that disease has significantly progressed (most paitnets with this die within a year)
- Ca> 2.6mmol/Lt
Malignant hypercalcaemia - treatment
- Fluid replacement (1-2L NaCl 0.9% over 24h)
- Given before bisphosphonates as nephrotoxic.
- Bisphosphonates: zolendronate or pamidronate
- Treatment effective for 2-4 weeks in 70-80% of pt
- Reduce dose in renal impairment
- Ca2+ levels fall after 48h and continue to decrease for 6/7 days
- Monitor
Zolendronate
4mg/100ml in normal saline for 15 mins
Pamidronate
- <3.5mmol/L = 60 mg
- > 3.5 mmol/L = 90 mg
- BOTH in normal saline over 2-4 hours
Malignant hypercalcaemia - MoA
- Due to parathyroid hormone-related protein
- Normally expressed in cells but also secreted by tumour cells
- PTHrP stimulates bone resorption, increasing osteoclast activity (breaks down old bones, releases calcium)
- Also increases calcium reabsorption so decreases urinary excretion of calcium
- Higher serum calcium
Malignant hypercalcaemia - Symptoms
- Symptoms typically present with >3mmol/L
- N+V
- Drowsiness
- Confusion
- Constipation
- Anorexia
- Fatigue
- Mood disturbances, delirium
- Symptoms are general, so regular monitoring of Ca levels is essential
Malignant hypercalcaemia - medical emergency
- > 4mmol/L
- Seizures
- Arrhythmias
- Untreated will die in a few days
Malignant spinal cord compression
- Palliative care emergency - urgent referral for MRI
- Complications of cancer where metastases in spine
MSCS - Symptoms
- Pain
- Motor deficits
- Autonomic deficits
- Sensory deficits
MSCC - Treatment
- Dexamethasone 16mg OD ASAP
- Analgesia
- Radiotherapy
- Surgery
Spinal cord compression
- Pressure on the spinal cord
- Nerves in the spinal cord swell and slow down or their blood supply is blocked.
- Nerves cannot function as normal.
Spinal cord compression - symptoms
- Progressive pain in spine
- Spinal pain aggravated by straining
- Nocturnal spinal pain preventing sleep
- Limb weakness
- Difficulty walking
- Bladder or bowel dysfunction
- Sensory defecits
Spinal cord compression - treatment
- Dexamethasone
- Reduces oedema
- Inhibits inflammatory response
- Delays onset of neurological symptoms
Neutropenic sepsis
- Medical emergency
- Neutrophil count <0.5 x 10^9/L and a temperature >38, or any symptoms or signs or sepsis
- Can occur in any pt who has received chemotherapy within the last 4 weeks
- Rapid progression of symptoms - leads to shock and death
- Rapid referral essential
Treatment of neutropenic sepsis
Broad spectrum abx IV within one hour
e.g. tazocin 4.5g TDS + gentamicin 5mg/kg OD